Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Terzolo

Showing results (61-70 of 181) with videos related to

Pageof 19
Sort By:
The Journal of Clinical Endocrinology and Metabolism|January 5, 2020
Adrenal Incidentalomas are Tied to Increased Risk of Diabetes: Findings from a Prospective StudyGiuseppe Reimondo, Elena Castellano, Maurizio Grosso, et al.
Frontiers in Endocrinology|January 21, 2022
Glucocorticoid Receptor Antagonism Upregulates Somatostatin Receptor Subtype 2 Expression in ACTH-Producing Neuroendocrine Tumors: New Insight Based on the Selective Glucocorticoid Receptor Modulator RelacorilantRosario Pivonello, Pamela N Munster, Massimo Terzolo, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 19, 2006
Matrix metalloproteinase type 2 expression in malignant adrenocortical tumors: Diagnostic and prognostic significance in a series of 50 adrenocortical carcinomasMarco Volante, Paola Sperone, Enrico Bollito, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 7, 2007
Laboratory differentiation of Cushing's syndromeGiuseppe Reimondo, Anna Pia, Silvia Bovio, et al.
The Journal of Clinical Endocrinology and Metabolism|March 1, 2007
Increased osteoprotegerin levels in Cushing's syndrome are associated with an adverse cardiovascular risk profileAndrea Dovio, Barbara Allasino, Enrico Palmas, et al.
Expert Opinion on Emerging Drugs|September 4, 2008
Emerging drugs for adrenocortical carcinomaAlfredo Berruti, Anna Ferrero, Paola Sperone, et al.
Endocrine|January 5, 2021
Frequency and outcome of SARS-CoV-2 infection in patients with adrenocortical carcinoma followed at a reference center in ItalyDeborah Cosentini, Salvatore Grisanti, Marta Laganà, et al.
Virchows Archiv : an International Journal of Pathology|July 6, 2004
Myxoid adrenocortical adenoma with a pseudoglandular patternEnrico R Bollito, Mauro Papotti, Francesco Porpiglia, et al.
European Journal of Endocrinology|February 8, 2012
Cortisol secretion, bone health, and bone loss: a cross-sectional and prospective study in normal non-osteoporotic women in the early postmenopausal periodGiangiacomo Osella, Massimo Ventura, Arianna Ardito, et al.
Annals of Surgical Oncology|October 28, 2022
Mitotane With or Without Cisplatin and Etoposide for Patients with a High Risk of Recurrence in Stages 1-3 Adrenocortical Cancer After SurgeryAmber Leila Sarvestani, Stephanie N Gregory, Martha E Teke, et al.
Pageof 19

Showing results (61-70 of 181) with videos related to

Sort By:
Pageof 19
The Journal of Clinical Endocrinology and Metabolism|January 5, 2020
Adrenal Incidentalomas are Tied to Increased Risk of Diabetes: Findings from a Prospective StudyGiuseppe Reimondo, Elena Castellano, Maurizio Grosso, et al.
Frontiers in Endocrinology|January 21, 2022
Glucocorticoid Receptor Antagonism Upregulates Somatostatin Receptor Subtype 2 Expression in ACTH-Producing Neuroendocrine Tumors: New Insight Based on the Selective Glucocorticoid Receptor Modulator RelacorilantRosario Pivonello, Pamela N Munster, Massimo Terzolo, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 19, 2006
Matrix metalloproteinase type 2 expression in malignant adrenocortical tumors: Diagnostic and prognostic significance in a series of 50 adrenocortical carcinomasMarco Volante, Paola Sperone, Enrico Bollito, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 7, 2007
Laboratory differentiation of Cushing's syndromeGiuseppe Reimondo, Anna Pia, Silvia Bovio, et al.
The Journal of Clinical Endocrinology and Metabolism|March 1, 2007
Increased osteoprotegerin levels in Cushing's syndrome are associated with an adverse cardiovascular risk profileAndrea Dovio, Barbara Allasino, Enrico Palmas, et al.
Expert Opinion on Emerging Drugs|September 4, 2008
Emerging drugs for adrenocortical carcinomaAlfredo Berruti, Anna Ferrero, Paola Sperone, et al.
Endocrine|January 5, 2021
Frequency and outcome of SARS-CoV-2 infection in patients with adrenocortical carcinoma followed at a reference center in ItalyDeborah Cosentini, Salvatore Grisanti, Marta Laganà, et al.
Virchows Archiv : an International Journal of Pathology|July 6, 2004
Myxoid adrenocortical adenoma with a pseudoglandular patternEnrico R Bollito, Mauro Papotti, Francesco Porpiglia, et al.
European Journal of Endocrinology|February 8, 2012
Cortisol secretion, bone health, and bone loss: a cross-sectional and prospective study in normal non-osteoporotic women in the early postmenopausal periodGiangiacomo Osella, Massimo Ventura, Arianna Ardito, et al.
Annals of Surgical Oncology|October 28, 2022
Mitotane With or Without Cisplatin and Etoposide for Patients with a High Risk of Recurrence in Stages 1-3 Adrenocortical Cancer After SurgeryAmber Leila Sarvestani, Stephanie N Gregory, Martha E Teke, et al.
Pageof 19